What to know about the medical community’s new heart health guidelines

the American Heart Association says. Credit: Getty Images
Maintaining a healthy weight lowers your risk for heart disease. Credit: Getty Images

Since the last National Heart Health Month, the medical community underwent a dramatic change in categorizing patients for heart disease prevention and treatment. Citing criticism over conflicts of interest as the main reason for the change, the National Institutes of Health handed over treatment guidelines to the American Cardiovascular Association and the American Heart Association.

“When you change any guidelines, it’s a big undertaking,” says Dr. Merle Myerson, Director of Mount Sinai St. Luke’s and Roosevelt Hospital’s Center for Cardiovascular Disease Prevention. “Guidelines decide who will be treated and who will not. The new guidelines are a drastic change in how to measure risk.”

The new system switches from monitoring individual blood cholesterol levels, along with other physiological factors, to grouping individuals into one of four complex categories. But Dr. Myerson’s fear is that lumping people into categories might miss some at-risk heart patients, particularly those with familial hypertension, who will be overlooked for testing and treatment.

“When the new guidelines were written, they took into account randomized trials, but not population studies, or epidemiological studies,” she says. “It used to be about knowing your numbers and meeting a target for cholesterol. Now, who should be on meds is split into four groups that benefit from statin therapy. Some people might not simply fall into a group.”

For the public and doctors used to the system of watching cholesterol numbers, the switch can cause confusion.

“Goals and targets are very helpful,” says Dr. Myerson. “In Europe and Canada, the guidelines were similar to our old ones, and have remained the same. I don’t know why it’s necessary to change them here in the U.S.”

Two new drugs

Dr. Myerson notes that the new changes call for a wider use in statins. Here are her thoughts on some other recently released heart meds:

Juxtapid, a low-density lipoprotein (LDL) lowering prescription medication: “This medication is for those with homozygous hypercholesterolemia and complex heterozygous familial hypercholesterolemia. This is very expensive ($250,000 per year) and may have significant side effects, including to the liver.”

Mipomersen, an injectable low-density lipoprotein (LDL) lowering medication: “This has the same indications as Juxtapid, but is less expensive at about $150,000 per year.”



News
Entertainment
Sports
Lifestyle
Local

Brooklyn man charged in roommate's stabbing death

A Brooklyn man accused of violently stabbing his roommate to death on Monday is in police custody and faces murder charges.

International

Dinosaurs could have survived asteroid strike

It turns out there is a good and a bad time for the planet to be hit by a meteor, and dinosaurs were just unlucky.…

National

OkCupid admits to Facebook-style experimenting on customers

By Sarah McBrideSAN FRANCISCO (Reuters) - OkCupid, a top U.S. matchmaking website, intentionally mismatched users to test its technology, the IAC/InterActive Corp service said on…

Local

MTA fares still increasing 4 percent in newly…

The agency said the 4 percent increases, previously announced in December, will remain steady even as the MTA deals with increasing labor costs.

Movies

Interview: Brendan Gleeson on the way 'Calvary' depicts…

Brendan Gleeson talks about how his new film "Calvary" began over drinks and how his character here is the opposite of the lead in "The Guard."

Movies

'Get on Up' producer Mick Jagger on the…

Mick Jagger, a producer on the James Brown biopic "Get on Up," talks about the time had to tell the singer some bad news and his favorite JB record.

Television

'Glee' star Lea Michele to appear on 'Sons…

"Glee" star Lea Michele has been confirmed as a guest star in the final season of "Sons of Anarchy."

Television

TV watch list, Monday, July 28: 'The Bachelorette'…

See Andi Dorfman make her big choice on tonight's 'Bachelorette' finale.

MLB

Angelo Cataldi: Ryan Howard deserves better from Phillies

Just last week, Ryan Howard endured the embarrassment of a benching that was inevitable, and yet still shocking.

NFL

Larry Donnell has inside track in Giants tight…

Little-known Larry Donnell of Grambling State currently has the inside track, as the second-year player has received the bulk of the first-team reps.

NFL

Computer to Jets: Start Michael Vick over Geno…

Jets general manager John Idzik says the choice of who starts between second-year quarterback Geno Smith and veteran Michael Vick will be a “Jets decision.”

MLB

Yankees looking to trade for Josh Willingham: Report

CBS Sports’ Jon Heyman reported Sunday the Yankees are interested in Twins outfielder Josh Willingham.

Travel

Glasgow: Hey, hey, the gangs aren't here

This European city has done a good job getting rid of its more violent residents and revitalizing with artists.

Education

Babson College tops list of best colleges for…

Money magazine has just released its inaugural list of "The Best Colleges for Your Money" -- and the answers have surprised many. Babson College, which…

Education

NYC teens learn how to develop apps during…

Through a program sponsored by CampInteractive, the high schoolers designed their own community-focused apps.

Tech

The Ministry of Silly Walks app is both…

Monty Python have dug into their back catalogue for cash-ins once more, but with the Ministry of Silly Walks app, they've made something that's fun too.